CARPENTER ROBERT J - 29 Jul 2021 Form 3 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Robert J. Carpenter
Issuer symbol
IMRX
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 20:53:01 UTC
Next filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMRX Class A Common Stock 606,666 29 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMRX Stock Option 29 Jul 2021 Class A Common Stock 111,153 $3.01 Direct F1
holding IMRX Series A Preferred Stock 29 Jul 2021 Class A Common Stock 94,585 Direct F2
holding IMRX Series B Preferred Stock 29 Jul 2021 Class A Common Stock 122,588 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on December 16, 2020 and then in equal monthly installments over the subsequent three years, subject to Mr. Carpenter's continued service to the Issuer's board of directors through each applicable vesting date.
F2 Each share of the Issuer's preferred stock is convertible on a one-for-one basis into shares of the Issuer's Class A common stock in certain circumstances and has no expiration date. The preferred stock will automatically convert into Class A common stock immediately prior to the closing of the Issuer's initial public offering.

Remarks:

Exhibit 24 - Power of Attorney